Curaleaf Holdings, Inc. (CURA)
NEO-L 
Summary
CURA Chart
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry consolidation. Behind the urge to merge is a significant shift in U.S. federal regulatory policy, encouraging better-capitalized operators to secure global supply chains before tax relief drives widespread multiple expansion.
Curaleaf raises Aurora Cannabis offer by 25%
Curaleaf Hldgs Inc. (OTCQX:CURLF), the Connecticut-based cannabis company, has raised its offer for Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB), a Canadian cannabis producer, by 25% to a total implied value of $5 per Aurora share in cash and stock. The new price is 86% above Aurora's 30-day volume-weighted average share price of $2.75 as of August 10, the day before Curaleaf announced its intention to make its initial offer.
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Cross-border consolidation in the cannabis industry has moved from executive speculation into aggressive dealmaking. As regulatory hurdles begin to clear across North America and Europe, operators are moving quickly to strengthen their finances and expand globally.
Curaleaf Holdings, Inc. (CURA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Curaleaf Holdings, Inc. ever had a stock split?
Curaleaf Holdings, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Boris Alexis Jordan CEO | NEO-L Exchange | CA23126M1023 ISIN |
| US Country | 5,554 Employees | - Last Dividend | 5 Jun 2026 Last Split | - IPO Date |
Overview
Curaleaf Holdings, Inc. stands as a prominent cannabis operator within the United States, encompassing its business operations into two main segments: Domestic Operations and International Operations. As a company, it is engaged in the cultivation, production, and sale of cannabis and related products, catering to both the retail and wholesale markets. With its headquarters based in New York, New York, Curaleaf has established itself as a key player in the industry, providing a wide range of cannabis products to a diverse clientele, while also spearheading initiatives in hemp-based product offerings and innovative cannabinoid applications.
Products and Services
- Flower, Pre-rolls, Flower Pots, and Dry-Herb Vaporizer Cartridges
Curaleaf offers an extensive selection of cannabis flower products, including pre-rolls for convenience, flower pots for personal use, and dry-herb vaporizer cartridges for a modern smoking experience. These products are designed to meet the varied preferences of consumers, offering high-quality cannabis strains cultivated under stringent standards.
- Concentrates for Vaporizing
The company provides a variety of concentrates specifically designed for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens. These products offer a discreet and efficient way to consume cannabis, with options available in different strains and potencies to cater to individual needs and preferences.
- Concentrates for Dabbing
For consumers who prefer dabbing, Curaleaf presents a selection of concentrates including mints, distillate droppers, and more. These products allow for a potent and customizable cannabis experience, suitable for both seasoned consumers and those looking to explore concentrated forms of cannabis.
- Mints, Topical Balms and Lotions, Tinctures, Lozenges, Capsules, and Edibles
Beyond traditional cannabis products, Curaleaf has expanded its portfolio to include a variety of alternative formats such as mints, topical balms and lotions for external use, tinctures and lozenges for easy consumption, capsules for precise dosing, and a wide range of edibles. These products are designed to offer consumers diverse ways to experience the benefits of cannabis, with a focus on convenience, discretion, and efficacy.
- Hemp-Based Products and Cannabinoids
Curaleaf also engages in the production and sale of hemp-based products and cannabinoids like cannabidiol (CBD) and cannabigerol (CBG). These offerings cater to the growing demand for non-psychoactive cannabinoids, known for their therapeutic benefits, and are available in various formulations to meet consumer needs in wellness and medicinal contexts.
Contact Information
